Jane Street »

Revance Therapeutics shares owned by Jane Street

Quarter-by-quarter ownership of Revance Therapeutics shares owned by Jane Street from 13F filings

Historical chart of Jane Street investment in Revance Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Revance Therapeutics held by Jane Street consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Revance Therapeutics by Jane Street

Quarter filed Position value Share count Share price at filing
2024-03-31 $171k 35k 4.92
2023-12-31 $206k 23k 8.79
2023-09-30 $744k 65k 11.47
2023-03-31 $589k 18k 32.21
2022-12-31 $3.4M 184k 18.46
2022-09-30 $2.9M 108k 27.00
2022-06-30 $1.2M 86k 13.82

Top funds holding Revance Therapeutics